Tämä sivu käännettiin automaattisesti, eikä käännösten tarkkuutta voida taata. Katso englanninkielinen versio lähdetekstiä varten.

Individualized Versus Non-Individualized Resistance Training

torstai 5. marraskuuta 2026 päivittänyt: Christophe Delecluse, Universitaire Ziekenhuizen KU Leuven

Räätälöity toimenpide ikääntymiseen liittyvän lihasvoiman ja toimintakyvyn heikkenemisen estämiseksi

Preserving functional ability is crucial for healthy aging. Unfortunately, age-related decreases in muscle power often lead to declines in functional ability. As power is the product of force and velocity, decreases in power can originate from changes in muscle force, contraction velocity, or both, varying between individuals. The primary method to prevent functional disability is power-based resistance training. Although training interventions are effective for most older adults, they do not induce substantial improvements in a subset of the population. These inconsistent outcomes may arise from neglecting the observed differences in the force-velocity (F-V) profiles between individuals. Therefore, this study provides a novel approach to resistance exercise, in which exercise dose is tailored according to the individual's F-V profile. The effectiveness of the tailored method will be assessed in a randomized control trial, comparing the effects of an individualized and a non-individualized 12-week training intervention on muscle power parameters and functional ability.

Tutkimuksen yleiskatsaus

Opintotyyppi

Interventio

Ilmoittautuminen (Todellinen)

80

Vaihe

  • Ei sovellettavissa

Yhteystiedot ja paikat

Tässä osiossa on tutkimuksen suorittajien yhteystiedot ja tiedot siitä, missä tämä tutkimus suoritetaan.

Opiskelupaikat

    • Vlaams-Brabant
      • Leuven, Vlaams-Brabant, Belgia, 3000
        • KU Leuven - Department of Movement Sciences

Osallistumiskriteerit

Tutkijat etsivät ihmisiä, jotka sopivat tiettyyn kuvaukseen, jota kutsutaan kelpoisuuskriteereiksi. Joitakin esimerkkejä näistä kriteereistä ovat henkilön yleinen terveydentila tai aiemmat hoidot.

Kelpoisuusvaatimukset

Opintokelpoiset iät

65 vuotta ja vanhemmat (Vanhempi Aikuinen)

Hyväksyy terveitä vapaaehtoisia

Joo

Sukupuolet, jotka voivat opiskella

Kaikki

Kuvaus

Inclusion Criteria:

  • Community-dwelling adults
  • At least 65 years old

Exclusion Criteria:

  • Systematic engagement in resistance exercise during the past year
  • Unstable cardiovascular disease, neuromuscular disease, acute infection or fever
  • Recent surgery
  • Lower-extremity injuries
  • Low levels of functional ability (i.e., SPPB score ≤ 9)
  • Cognitive malfunctioning (i.e., Mini-Mental State Examination < 24)

Opintosuunnitelma

Tässä osiossa on tietoja tutkimussuunnitelmasta, mukaan lukien kuinka tutkimus on suunniteltu ja mitä tutkimuksella mitataan.

Miten tutkimus on suunniteltu?

Suunnittelun yksityiskohdat

  • Ensisijainen käyttötarkoitus: Ennaltaehkäisy
  • Jako: Satunnaistettu
  • Inventiomalli: Rinnakkaistehtävä
  • Naamiointi: Ei mitään (avoin tarra)

Aseet ja interventiot

Osallistujaryhmä / Arm
Interventio / Hoito
Kokeellinen: Individualized resistance exercise program

Individualized exercise dose. All individuals perform resistance exercises at a load that targets their deficit. Individuals with a velocity deficit train at low loads while individuals with a force deficit train at high loads.

2x/week, 35-45 min sessions, on leg press machine

Active Comparator: Non-individualized resistance exercise program

Non-individualized exercise dose. All individuals perform resistance exercises at a load that does not target their deficit. Individuals with a velocity deficit train at high loads while individuals with a force deficit train at low loads.

2x/week, 35-45 min sessions, on leg press machine

Mitä tutkimuksessa mitataan?

Ensisijaiset tulostoimenpiteet

Tulosmittaus
Toimenpiteen kuvaus
Aikaikkuna
Maximal power (Pmax)
Aikaikkuna: Change from baseline at 6 and 12 weeks

Participants performed explosive unilateral leg extensions with the dominant leg at five submaximal loads on a pneumatic leg press (Leg Press Air 400, Keiser, USA). Submaximal loads were scaled to the estimated maximal isometric force derived from the familiarization session. The three lighter loads were performed three times each and the two heavier loads twice, with the repetition yielding the highest mean concentric velocity retained for analysis. Participants subsequently performed single repetitions at incrementally increasing loads until 1-RM was reached. Rest intervals were adjusted according to the load of the preceding trial: 60 s after the three lightest loads, 90 s after the two heavier loads, and 120 s during the incremental trials leading to 1-RM. For each load, the mean concentric velocity of the best trial was used to establish the individual force-velocity (F-V) relationship using linear regression, from which the maximal power (Pmax; W) was estimated.

Change from baseline at 6 and 12 weeks
Maximal isometric force (F0)
Aikaikkuna: Change from baseline at 6 and 12 weeks

Participants performed explosive unilateral leg extensions with the dominant leg at five submaximal loads on a pneumatic leg press (Leg Press Air 400, Keiser, USA). Submaximal loads were scaled to the estimated maximal isometric force derived from the familiarization session. The three lighter loads were performed three times each and the two heavier loads twice, with the repetition yielding the highest mean concentric velocity retained for analysis. Participants subsequently performed single repetitions at incrementally increasing loads until 1-RM was reached. Rest intervals were adjusted according to the load of the preceding trial: 60 s after the three lightest loads, 90 s after the two heavier loads, and 120 s during the incremental trials leading to 1-RM. For each load, the mean concentric velocity of the best trial was used to establish the individual force-velocity (F-V) relationship using linear regression, from which maximal isometric force (F0; N) was estimated.

Change from baseline at 6 and 12 weeks
Maximal unloaded velocity (V0)
Aikaikkuna: Change from baseline at 6 and 12 weeks

Participants performed explosive unilateral leg extensions with the dominant leg at five submaximal loads on a pneumatic leg press (Leg Press Air 400, Keiser, USA). Submaximal loads were scaled to the estimated maximal isometric force derived from the familiarization session. The three lighter loads were performed three times each and the two heavier loads twice, with the repetition yielding the highest mean concentric velocity retained for analysis. Participants subsequently performed single repetitions at incrementally increasing loads until 1-RM was reached. Rest intervals were adjusted according to the load of the preceding trial: 60 s after the three lightest loads, 90 s after the two heavier loads, and 120 s during the incremental trials leading to 1-RM. For each load, the mean concentric velocity of the best trial was used to establish the individual force-velocity (F-V) relationship using linear regression, from which maximal unloaded velocity (V0; m/s) was estimated.

Change from baseline at 6 and 12 weeks
Force-velocity slope
Aikaikkuna: Change from baseline at 6 and 12 weeks

Participants performed explosive unilateral leg extensions with the dominant leg at five submaximal loads on a pneumatic leg press (Leg Press Air 400, Keiser, USA). Submaximal loads were scaled to the estimated maximal isometric force derived from the familiarization session. The three lighter loads were performed three times each and the two heavier loads twice, with the repetition yielding the highest mean concentric velocity retained for analysis. Participants subsequently performed single repetitions at incrementally increasing loads until 1-RM was reached. Rest intervals were adjusted according to the load of the preceding trial: 60 s after the three lightest loads, 90 s after the two heavier loads, and 120 s during the incremental trials leading to 1-RM. For each load, the mean concentric velocity of the best trial was used to establish the individual force-velocity (F-V) relationship using linear regression, from which the F-V slope (Ns/m) was derived.

Change from baseline at 6 and 12 weeks

Toissijaiset tulostoimenpiteet

Tulosmittaus
Toimenpiteen kuvaus
Aikaikkuna
Short Physical Performance Battery (SPPB)
Aikaikkuna: Score at baseline

Total score on the SPPB (min 0, max 12, higher scores indicate better performance)

Score at baseline
Hand grip strength
Aikaikkuna: Change from baseline at 6 and 12 weeks

Maximal grip strength (kg) of the dominant hand using an isometric dynamometer adjusted for hand size

Change from baseline at 6 and 12 weeks
Maximal gait speed
Aikaikkuna: Change from baseline at 6 and 12 weeks

The average time (s) to walk 10m as fast as possible

Change from baseline at 6 and 12 weeks
Countermovement jump
Aikaikkuna: Change from baseline at 6 and 12 weeks

The jump height (mm) in a countermovement jump

Change from baseline at 6 and 12 weeks
Timed up-and-go
Aikaikkuna: Change from baseline at 6 and 12 weeks

The time (s) needed to stand up from a chair, walk 3 m, turn, walk back and sit down again as fast as possible

Change from baseline at 6 and 12 weeks
5-repetition sit-to-stand time
Aikaikkuna: Change from baseline at 6 and 12 weeks

The time (s) needed to complete the 5-repetition sit-to-stand test

Change from baseline at 6 and 12 weeks
5-repetition sit-to-stand power
Aikaikkuna: Change from baseline at 6 and 12 weeks

The average power (watt) produced during the 5-repetition sit-to-stand test

Change from baseline at 6 and 12 weeks
30-second sit-to-stand repetitions
Aikaikkuna: Change from baseline at 6 and 12 weeks

The number of repetitions completed during the 30-second sit-to-stand test

Change from baseline at 6 and 12 weeks
30-second sit-to-stand power
Aikaikkuna: Change from baseline at 6 and 12 weeks

The average power (watt) produced during the 30-second sit-to-stand test

Change from baseline at 6 and 12 weeks
Stair ascent time
Aikaikkuna: Change from baseline at 6 and 12 weeks

The time (s) needed to ascend a flight of stairs

Change from baseline at 6 and 12 weeks
Stair ascent power
Aikaikkuna: Change from baseline at 6 and 12 weeks

The average power (Watt) produced during the stair ascent test

Change from baseline at 6 and 12 weeks
Exercise adherence
Aikaikkuna: Total adherence over 12-week period

Number of sessions attended as a percentage of total sessions planned

Total adherence over 12-week period
Absolute training load
Aikaikkuna: Consistently recorded throughout the 12-week intervention

The absolute load (kg) used during training sessions

Consistently recorded throughout the 12-week intervention
Relative training load
Aikaikkuna: Consistently recorded throughout the 12-week intervention

The relative load (%1RM) used during training sessions

Consistently recorded throughout the 12-week intervention
Number of repetitions
Aikaikkuna: Consistently recorded throughout the 12-week intervention

The number of repetitions (n) completed per set

Consistently recorded throughout the 12-week intervention
Highest movement velocity within a set
Aikaikkuna: Consistently recorded throughout the 12-week intervention

The velocity (m/s) of the fastest repetition in a set (Vmax)

Consistently recorded throughout the 12-week intervention
Lowest movement velocity within a set
Aikaikkuna: Consistently recorded throughout the 12-week intervention

The velocity (m/s) of the slowest repetition in a set (Vmin)

Consistently recorded throughout the 12-week intervention
Velocity loss
Aikaikkuna: Consistently recorded throughout the 12-week intervention

The percentage difference between the highest and lowest movement velocity in a set = ([Vmax - Vmin] / Vmax) × 100

Consistently recorded throughout the 12-week intervention
Set-volume index
Aikaikkuna: Consistently recorded throughout the 12-week intervention

The number of repetitions × relative load (%1-RM) per set

Consistently recorded throughout the 12-week intervention
Session-volume index
Aikaikkuna: Consistently recorded throughout the 12-week intervention

The sum of set volumes per session

Consistently recorded throughout the 12-week intervention

Yhteistyökumppanit ja tutkijat

Täältä löydät tähän tutkimukseen osallistuvat ihmiset ja organisaatiot.

Julkaisuja ja hyödyllisiä linkkejä

Tutkimusta koskevien tietojen syöttämisestä vastaava henkilö toimittaa nämä julkaisut vapaaehtoisesti. Nämä voivat koskea mitä tahansa tutkimukseen liittyvää.

Opintojen ennätyspäivät

Nämä päivämäärät seuraavat ClinicalTrials.gov-sivustolle lähetettyjen tutkimustietueiden ja yhteenvetojen edistymistä. National Library of Medicine (NLM) tarkistaa tutkimustiedot ja raportoidut tulokset varmistaakseen, että ne täyttävät tietyt laadunvalvontastandardit, ennen kuin ne julkaistaan ​​julkisella verkkosivustolla.

Opi tärkeimmät päivämäärät

Opiskelun aloitus (Todellinen)

Maanantai 20. toukokuuta 2024

Ensisijainen valmistuminen (Todellinen)

Torstai 4. joulukuuta 2025

Opintojen valmistuminen (Todellinen)

Torstai 4. joulukuuta 2025

Opintoihin ilmoittautumispäivät

Ensimmäinen lähetetty

Tiistai 5. maaliskuuta 2024

Ensimmäinen toimitettu, joka täytti QC-kriteerit

Keskiviikko 5. kesäkuuta 2024

Ensimmäinen Lähetetty (Todellinen)

Maanantai 10. kesäkuuta 2024

Tutkimustietojen päivitykset

Viimeisin päivitys julkaistu (Todellinen)

Perjantai 6. marraskuuta 2026

Viimeisin lähetetty päivitys, joka täytti QC-kriteerit

Torstai 5. marraskuuta 2026

Viimeksi vahvistettu

Sunnuntai 1. marraskuuta 2026

Lisää tietoa

Tähän tutkimukseen liittyvät termit

Muut tutkimustunnusnumerot

  • S68434

Yksittäisten osallistujien tietojen suunnitelma (IPD)

Aiotko jakaa yksittäisten osallistujien tietoja (IPD)?

EI

Lääke- ja laitetiedot, tutkimusasiakirjat

Tutkii yhdysvaltalaista FDA sääntelemää lääkevalmistetta

Ei

Tutkii yhdysvaltalaista FDA sääntelemää laitetuotetta

Ei

Nämä tiedot haettiin suoraan verkkosivustolta clinicaltrials.gov ilman muutoksia. Jos sinulla on pyyntöjä muuttaa, poistaa tai päivittää tutkimustietojasi, ota yhteyttä register@clinicaltrials.gov. Heti kun muutos on otettu käyttöön osoitteessa clinicaltrials.gov, se päivitetään automaattisesti myös verkkosivustollemme .

Tilaa